2023 Form 5500 filing — Diamond Drugs, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015131240NAL0014695347001) for Diamond Drugs, Inc. 401(K) Plan, reported by Diamond Drugs, Inc. under EIN 25-1378278 and plan number 001. It reports 873 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241015131240NAL0014695347001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Diamond Drugs, Inc.
- EIN
- 25-1378278
- Plan number
- 001
- Location
- Indiana, PA
- Participants
- 873
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $40,590,722
- Total liabilities (EOY)
- $108,279
- Net assets (EOY)
- $40,482,443
- Employer contributions
- $630,468
- Participant contributions
- $2,730,869
- Total income / additions
- $8,324,651
- Benefits paid
- $2,043,520
- Administrative expenses
- $4,350
- Total expenses
- $2,156,149
- Net increase / (decrease)
- $6,168,502
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Lincoln Retirement | CUSTODIAN | $39,303 | not reported in the loaded dataset |
| Anchor 3(16) Fiduciary Services LLC | PLAN ADMINISTRATOR | $10,900 | not reported in the loaded dataset |
| M2b Retirement Consulting, LLC | TPA | $7,370 | not reported in the loaded dataset |